Modified mucoadhesive polymers for the peroral administration of mainly elastase degradable therapeutic (poly)peptides
- 1 August 1997
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 47 (2) , 113-121
- https://doi.org/10.1016/s0168-3659(97)01627-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Development and Analysis of a Polymer Protecting from Luminal Enzymatic Degradation Caused by α-ChymotrypsinDrug Development and Industrial Pharmacy, 1997
- Effects of Polyacrylic Polymers on the Degradation of Insulin and Peptide Drugs by Chymotrypsin and TrypsinJournal of Pharmacy and Pharmacology, 1996
- Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fateJournal of Controlled Release, 1995
- Degradation of proteins by guinea pig intestinal enzymesInternational Journal of Pharmaceutics, 1993
- Effects of the Mucoadhesive Polymer Polycarbophil on the Intestinal Absorption of a Peptide Drug in the RatJournal of Pharmacy and Pharmacology, 1992
- Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic ratsInternational Journal of Pharmaceutics, 1992
- Novel oral microspheres of insulin with protease inhibitor protecting from enzymatic degradationInternational Journal of Pharmaceutics, 1992
- Transport of proteins through the membranes of the adult gastro-intestinal tract — a potential for drug delivery?Advanced Drug Delivery Reviews, 1989
- Bioadhesive Polymers as Platforms for Oral Controlled Drug Delivery II: Synthesis and Evaluation of Some Swelling, Water-Insoluble Bioadhesive PolymersJournal of Pharmaceutical Sciences, 1985
- Cytotoxic effects of protease inhibitors on human cells. 2. Effect of elastatinalCancer Letters, 1980